Press release -
Isabelle Ducellier new CEO of Orkla Health
Isabelle Ducellier has been appointed CEO of Orkla portfolio company Orkla Health.
Orkla Health's Board of Directors has appointed Isabelle Ducellier (54) as new CEO. She succeeds Hege Holter Brekke, who was appointed EVP & Investment Executive in Orkla ASA on 1 March 2023, in connection with Orkla transforming to an investment company and Orkla Health being established as one of 12 new portfolio companies.
Ms Ducellier comes from the position as CEO for Swedish healthcare company BioGaia group, where she has been since 2018. Prior to that, she has held various managerial positions, such as General Secretary at Swedish Childhood Cancer Fund, Associate Partner at McKinsey, and CEO of Pernod Ricard Sweden. She has a Master’s degree in international marketing from EM Lyon and an Executive MBA from Harvard Business School.
Ms Ducellier has several years of experience of board work in a number of companies, including several of the BioGaia companies, Arcus, Björn Borg, and Jönköping Business School.
Maria Syse-Nybraaten, Chair of the Board of Directors in Orkla Health, commented, “We are very pleased that Isabelle Ducellier has accepted the position as the new CEO of Orkla Health. Her extensive business experience from the consumer health sphere as well as from operating both local and global brands is very relevant for the journey Orkla Health is setting out for. Isabelle’s drive and relevant expertise in the field will make a strong and valuable contribution in the establishment of Orkla Health as a new independent portfolio company”.
Isabelle Ducellier will take up her position in the autumn. She will report to the Board of Directors of Orkla Health.
About Orkla Health
Orkla Health is a leading Nordic branded consumer health company with international niche positions within Food Supplements, Oral Care, Wound Care and Functional Personal Care. It also includes companies NutraQ and Healthspan. The company has a strong commercial presence in the Nordics, Baltics and Poland, but is also represented in several other countries with distribution in over 60 markets. Orkla Health has several strong brands, such as Möller’s, Jordan, Vitalab, OSL, Cederroth First Aid, Salvequick, Livol, Nutrilett, Maxim, Collett, Solidox, and CuraMed.
About Orkla ASA
Orkla ASA is a leading industrial investment company. Its scope of activity is brands and consumer-oriented companies. At present, Orkla has 12 portfolio companies. Orkla has a long-term, industrial approach to its portfolio companies. We invest in companies where we can contribute to further value creation through our industry expertise, consumer insight and experience in building leading brands. Through active portfolio management we target fast-growing consumer segments and markets. Operating revenues (BNOK) for 2022 was 58.4, number of employees was 20.500. Orkla ASA is listed on the Oslo Stock Exchange.
Topics
Categories
Orkla ASA is a leading industrial investment company. Its scope of activity is brands and consumer-oriented companies. At present, Orkla has 12 portfolio companies.
Orkla has a long-term, industrial approach to its portfolio companies. We invest in companies where we can contribute to further value creation through our industry expertise, consumer insight and experience in building leading brands. Through active portfolio management we target fast-growing consumer segments and markets.
Orkla ASA is listed on the Oslo Stock Exchange.
